Global Cellular Encapsulation Market Research Report 2024

Publication ID:

PB505252362

Publication Date:

May 10, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Cell encapsulation has been suggested as a means to protect the cells from the hostile microenvironment in the recipient tissue and provide an opportunity for the cells to survive
The global Cellular Encapsulation market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Cellular Encapsulation is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cellular Encapsulation is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Cellular Encapsulation in Biotechnology is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Cellular Encapsulation include Living Cell Technologies, Neurotech Pharmaceuticals, NovaMatri, PharmaCyte Biotech, Sigma-Aldrich, Novo Nordisk, Semma Therapeutics, Evotec and ViaCyte, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cellular Encapsulation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cellular Encapsulation.
Report Scope
The Cellular Encapsulation market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cellular Encapsulation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cellular Encapsulation companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Living Cell Technologies
Neurotech Pharmaceuticals
NovaMatri
PharmaCyte Biotech
Sigma-Aldrich
Novo Nordisk
Semma Therapeutics
Evotec
ViaCyte
Austrianova
Eli Lilly and Sigilon
Segment by Type
Alginate
Chitosan
Hydrogels
Siliceous Encapsulates
Cellulose Sulphate
Others
Segment by Application
Biotechnology
Healthcare
Research
Cosmetics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cellular Encapsulation companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cellular Encapsulation Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Alginate
1.2.3 Chitosan
1.2.4 Hydrogels
1.2.5 Siliceous Encapsulates
1.2.6 Cellulose Sulphate
1.2.7 Others
1.3 Market by Application
1.3.1 Global Cellular Encapsulation Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biotechnology
1.3.3 Healthcare
1.3.4 Research
1.3.5 Cosmetics
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cellular Encapsulation Market Perspective (2019-2030)
2.2 Cellular Encapsulation Growth Trends by Region
2.2.1 Global Cellular Encapsulation Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cellular Encapsulation Historic Market Size by Region (2019-2024)
2.2.3 Cellular Encapsulation Forecasted Market Size by Region (2025-2030)
2.3 Cellular Encapsulation Market Dynamics
2.3.1 Cellular Encapsulation Industry Trends
2.3.2 Cellular Encapsulation Market Drivers
2.3.3 Cellular Encapsulation Market Challenges
2.3.4 Cellular Encapsulation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cellular Encapsulation Players by Revenue
3.1.1 Global Top Cellular Encapsulation Players by Revenue (2019-2024)
3.1.2 Global Cellular Encapsulation Revenue Market Share by Players (2019-2024)
3.2 Global Cellular Encapsulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cellular Encapsulation Revenue
3.4 Global Cellular Encapsulation Market Concentration Ratio
3.4.1 Global Cellular Encapsulation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cellular Encapsulation Revenue in 2023
3.5 Cellular Encapsulation Key Players Head office and Area Served
3.6 Key Players Cellular Encapsulation Product Solution and Service
3.7 Date of Enter into Cellular Encapsulation Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cellular Encapsulation Breakdown Data by Type
4.1 Global Cellular Encapsulation Historic Market Size by Type (2019-2024)
4.2 Global Cellular Encapsulation Forecasted Market Size by Type (2025-2030)
5 Cellular Encapsulation Breakdown Data by Application
5.1 Global Cellular Encapsulation Historic Market Size by Application (2019-2024)
5.2 Global Cellular Encapsulation Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cellular Encapsulation Market Size (2019-2030)
6.2 North America Cellular Encapsulation Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cellular Encapsulation Market Size by Country (2019-2024)
6.4 North America Cellular Encapsulation Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cellular Encapsulation Market Size (2019-2030)
7.2 Europe Cellular Encapsulation Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cellular Encapsulation Market Size by Country (2019-2024)
7.4 Europe Cellular Encapsulation Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cellular Encapsulation Market Size (2019-2030)
8.2 Asia-Pacific Cellular Encapsulation Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cellular Encapsulation Market Size by Region (2019-2024)
8.4 Asia-Pacific Cellular Encapsulation Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cellular Encapsulation Market Size (2019-2030)
9.2 Latin America Cellular Encapsulation Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cellular Encapsulation Market Size by Country (2019-2024)
9.4 Latin America Cellular Encapsulation Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cellular Encapsulation Market Size (2019-2030)
10.2 Middle East & Africa Cellular Encapsulation Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cellular Encapsulation Market Size by Country (2019-2024)
10.4 Middle East & Africa Cellular Encapsulation Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Living Cell Technologies
11.1.1 Living Cell Technologies Company Detail
11.1.2 Living Cell Technologies Business Overview
11.1.3 Living Cell Technologies Cellular Encapsulation Introduction
11.1.4 Living Cell Technologies Revenue in Cellular Encapsulation Business (2019-2024)
11.1.5 Living Cell Technologies Recent Development
11.2 Neurotech Pharmaceuticals
11.2.1 Neurotech Pharmaceuticals Company Detail
11.2.2 Neurotech Pharmaceuticals Business Overview
11.2.3 Neurotech Pharmaceuticals Cellular Encapsulation Introduction
11.2.4 Neurotech Pharmaceuticals Revenue in Cellular Encapsulation Business (2019-2024)
11.2.5 Neurotech Pharmaceuticals Recent Development
11.3 NovaMatri
11.3.1 NovaMatri Company Detail
11.3.2 NovaMatri Business Overview
11.3.3 NovaMatri Cellular Encapsulation Introduction
11.3.4 NovaMatri Revenue in Cellular Encapsulation Business (2019-2024)
11.3.5 NovaMatri Recent Development
11.4 PharmaCyte Biotech
11.4.1 PharmaCyte Biotech Company Detail
11.4.2 PharmaCyte Biotech Business Overview
11.4.3 PharmaCyte Biotech Cellular Encapsulation Introduction
11.4.4 PharmaCyte Biotech Revenue in Cellular Encapsulation Business (2019-2024)
11.4.5 PharmaCyte Biotech Recent Development
11.5 Sigma-Aldrich
11.5.1 Sigma-Aldrich Company Detail
11.5.2 Sigma-Aldrich Business Overview
11.5.3 Sigma-Aldrich Cellular Encapsulation Introduction
11.5.4 Sigma-Aldrich Revenue in Cellular Encapsulation Business (2019-2024)
11.5.5 Sigma-Aldrich Recent Development
11.6 Novo Nordisk
11.6.1 Novo Nordisk Company Detail
11.6.2 Novo Nordisk Business Overview
11.6.3 Novo Nordisk Cellular Encapsulation Introduction
11.6.4 Novo Nordisk Revenue in Cellular Encapsulation Business (2019-2024)
11.6.5 Novo Nordisk Recent Development
11.7 Semma Therapeutics
11.7.1 Semma Therapeutics Company Detail
11.7.2 Semma Therapeutics Business Overview
11.7.3 Semma Therapeutics Cellular Encapsulation Introduction
11.7.4 Semma Therapeutics Revenue in Cellular Encapsulation Business (2019-2024)
11.7.5 Semma Therapeutics Recent Development
11.8 Evotec
11.8.1 Evotec Company Detail
11.8.2 Evotec Business Overview
11.8.3 Evotec Cellular Encapsulation Introduction
11.8.4 Evotec Revenue in Cellular Encapsulation Business (2019-2024)
11.8.5 Evotec Recent Development
11.9 ViaCyte
11.9.1 ViaCyte Company Detail
11.9.2 ViaCyte Business Overview
11.9.3 ViaCyte Cellular Encapsulation Introduction
11.9.4 ViaCyte Revenue in Cellular Encapsulation Business (2019-2024)
11.9.5 ViaCyte Recent Development
11.10 Austrianova
11.10.1 Austrianova Company Detail
11.10.2 Austrianova Business Overview
11.10.3 Austrianova Cellular Encapsulation Introduction
11.10.4 Austrianova Revenue in Cellular Encapsulation Business (2019-2024)
11.10.5 Austrianova Recent Development
11.11 Eli Lilly and Sigilon
11.11.1 Eli Lilly and Sigilon Company Detail
11.11.2 Eli Lilly and Sigilon Business Overview
11.11.3 Eli Lilly and Sigilon Cellular Encapsulation Introduction
11.11.4 Eli Lilly and Sigilon Revenue in Cellular Encapsulation Business (2019-2024)
11.11.5 Eli Lilly and Sigilon Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Living Cell Technologies
Neurotech Pharmaceuticals
NovaMatri
PharmaCyte Biotech
Sigma-Aldrich
Novo Nordisk
Semma Therapeutics
Evotec
ViaCyte
Austrianova
Eli Lilly and Sigilon

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂